The Drexel University College of Medicine has recently conducted a new research on organ transplant surgeries, in order to evaluate the risks to which patients are exposed. The most important finding is that every person who undergoes such a procedure is prone to turn into a skin cancer patient. Moreover, it seems like African-American patients are more likely to develop the disease.
The new research led by specialists shows that skin cancer can affect patients who underwent organ transplant surgery, regardless of their race. However, there are details which make the difference when treating African-American patients, as well as other minority patients. Dermatologists must take this into consideration when treating them.
More than two hundred minorities patients, African-Americans included, were participants in the study, and all of them have been through organ transplant surgery previously. Researchers discovered that six percent of them were prone to develop skin cancer. The signs of the disease were several lesions discovered on the patients.
The specialists who conducted the study suggest that patients who are to undergo organ transplant must be tested for skin cancer twice: once before the surgery, and again after the surgery. They say that there are no such regulations in the medical system. According to them, the postoperative evolution happens more often with white patients. Reports show that African-American patients under the same circumstances are rarely investigated for skin cancer.
Researchers explain that skin cancer can emerge because of the side-effects of medications which are administered to both white and nonwhite patients. Another cause is prolonged exposure to the sun, which the doctors found more common with Chinese people rather than other races. Apart from African-American patients, there were also Hispanic and Asian people.
The authors of the study also noted that skin cancer develops more aggressive forms with transplant patients rather than with other patients. They also suggest that when treating the disease, it is crucial to take into account the racial features of patients.
The Drexel Dermatology Center for Transplant Patients, where the study was conducted, has been treating skin cancer in minority patients for five years, since its opening. It was naturally that they should develop such research. Their results are important for the entire medical community.
The new study showing the connection between organ transplant patients and skin cancer was published in JAMA Dermatology earlier this week.
Image courtesy of: Wikipedia